Goldman Sachs Group Inc. boosted its holdings in Halyard Health Inc (NYSE:HYH) by 5.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,709,355 shares of the medical instruments supplier’s stock after acquiring an additional 91,378 shares during the period. Goldman Sachs Group Inc. owned 3.65% of Halyard Health worth $78,938,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also modified their holdings of the stock. ING Groep NV grew its stake in Halyard Health by 23.2% in the 4th quarter. ING Groep NV now owns 7,060 shares of the medical instruments supplier’s stock valued at $326,000 after acquiring an additional 1,329 shares during the last quarter. Allianz Asset Management GmbH boosted its stake in shares of Halyard Health by 2.6% during the 3rd quarter. Allianz Asset Management GmbH now owns 53,822 shares of the medical instruments supplier’s stock worth $2,424,000 after purchasing an additional 1,360 shares during the last quarter. Rhumbline Advisers boosted its stake in shares of Halyard Health by 1.4% during the 3rd quarter. Rhumbline Advisers now owns 101,813 shares of the medical instruments supplier’s stock worth $4,585,000 after purchasing an additional 1,376 shares during the last quarter. UBS Asset Management Americas Inc. boosted its stake in shares of Halyard Health by 4.1% during the 4th quarter. UBS Asset Management Americas Inc. now owns 35,374 shares of the medical instruments supplier’s stock worth $1,634,000 after purchasing an additional 1,400 shares during the last quarter. Finally, Mutual of America Capital Management LLC boosted its stake in shares of Halyard Health by 3.8% during the 4th quarter. Mutual of America Capital Management LLC now owns 39,443 shares of the medical instruments supplier’s stock worth $1,821,000 after purchasing an additional 1,462 shares during the last quarter. 91.34% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Halyard Health Inc (HYH) opened at $46.15 on Friday. Halyard Health Inc has a 12 month low of $35.24 and a 12 month high of $50.99. The stock has a market cap of $2,187.88, a PE ratio of 20.10, a price-to-earnings-growth ratio of 5.46 and a beta of 1.60. The company has a current ratio of 2.98, a quick ratio of 2.74 and a debt-to-equity ratio of 0.45.
Halyard Health (NYSE:HYH) last released its quarterly earnings results on Tuesday, February 27th. The medical instruments supplier reported $0.73 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.50 by $0.23. Halyard Health had a net margin of 5.82% and a return on equity of 6.98%. The company had revenue of $428.10 million for the quarter, compared to analysts’ expectations of $413.94 million. During the same period last year, the company earned $0.50 EPS. The firm’s revenue for the quarter was up 4.4% compared to the same quarter last year. sell-side analysts predict that Halyard Health Inc will post 0.96 earnings per share for the current fiscal year.
HYH has been the topic of several analyst reports. TheStreet raised shares of Halyard Health from a “c+” rating to a “b” rating in a research note on Monday, December 4th. Zacks Investment Research raised shares of Halyard Health from a “hold” rating to a “buy” rating and set a $53.00 price target on the stock in a research note on Wednesday, December 6th. Finally, ValuEngine raised shares of Halyard Health from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The company has an average rating of “Buy” and an average price target of $49.33.
COPYRIGHT VIOLATION WARNING: “Goldman Sachs Group Inc. Raises Position in Halyard Health Inc (HYH)” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another publication, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this article can be read at https://www.dispatchtribunal.com/2018/03/16/goldman-sachs-group-inc-raises-position-in-halyard-health-inc-hyh.html.
Halyard Health Profile
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health Inc (NYSE:HYH).
Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with MarketBeat.com's FREE daily email newsletter.